Acceleron Pharma
XLRN
#1819
Rank
โ‚น986.32 B
Marketcap
โ‚น16,128
Share price
0.00%
Change (1 day)
15,948.59%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: โ‚น986.32 Billion

As of December 2025 Acceleron Pharma has a market cap of โ‚น986.32 Billion. This makes Acceleron Pharma the world's 1819th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022โ‚น904.59 B11.18%
2021โ‚น813.65 B44.32%
2020โ‚น563.76 B180.68%
2019โ‚น200.85 B42.58%
2018โ‚น140.86 B14.92%
2017โ‚น122.57 B87.26%
2016โ‚น65.46 B-39.36%
2015โ‚น107.94 B34.8%
2014โ‚น80.08 B15.47%
2013โ‚น69.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚น15.762 T 1,498.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.159 T 625.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น45.283 T 4,491.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น1.88 B-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น13.05 B-98.68%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚น4.39 B-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น12.845 T 1,202.37%๐Ÿ‡บ๐Ÿ‡ธ USA